|
Volumn 346, Issue 11, 2002, Pages 855-856
|
Controlling spending for prescription drugs
a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;
COST CONTROL;
COST EFFECTIVENESS ANALYSIS;
DRUG COST;
EDITORIAL;
HEALTH CARE POLICY;
HEALTH CARE UTILIZATION;
HEALTH INSURANCE;
HEALTH PROGRAM;
PRESCRIPTION;
PRIORITY JOURNAL;
UNITED STATES;
BRITISH COLUMBIA;
CALIFORNIA;
COST SAVINGS;
COST SHARING;
DRUG COSTS;
INSURANCE COVERAGE;
INSURANCE, PHARMACEUTICAL SERVICES;
MEDICARE;
PRESCRIPTION FEES;
PRESCRIPTIONS, DRUG;
RATE SETTING AND REVIEW;
UNITED STATES;
|
EID: 0037076039
PISSN: 00284793
EISSN: None
Source Type: Journal
DOI: 10.1056/NEJM200203143461113 Document Type: Editorial |
Times cited : (25)
|
References (7)
|